A combination of the ACC inhibitor GS-0976 and the nonsteroidal FXR agonist GS-9674 improves hepatic steatosis, biochemistry, and stiffness in patients with non-alcoholic steatohepatitis Lawitz, E., Gane, E., Ruane, P., Herring, J., Younes, Z. H., Kwo, P., Zhang, J., Jia, C., Chuang, J., Mccolgan, B., Chung, C., Subramanian, M., Myers, R., Middleton, M., Li, K., Hellerstein, M., Noureddin, M., Harrison, S., Loomba, R. ELSEVIER SCIENCE BV. 2019: E794

View details for Web of Science ID 000463481703339